| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/23/2005 | WO2005047494A3 Haematopoietic stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them |
| 06/23/2005 | WO2005042575A3 Method for down-regulation of vegf |
| 06/23/2005 | WO2005040210A3 Novel cxcl8 antagonists |
| 06/23/2005 | WO2005040203A3 Msp-3-like family of genes |
| 06/23/2005 | WO2005040202A3 Stabilized alpha-helical peptides |
| 06/23/2005 | WO2005037863A9 Alternative splicing factors polynucleotides, polypeptides and uses thereof |
| 06/23/2005 | WO2005030798A3 TNFαCONVERTING ENZYME INHIBITORY AGENTS AND STIMULATORY AGENTS- |
| 06/23/2005 | WO2005030119A3 Botulinum toxin a peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy |
| 06/23/2005 | WO2005030032A3 Use of islet glucose-6-phosphatase related protein as a diagnostic tool and therapeutic target for autoimmune diabetes |
| 06/23/2005 | WO2005029086A3 Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a10 (ust3-like2) (slc22a10) |
| 06/23/2005 | WO2005026200A3 Lawsonia intracellularis subunit vaccine |
| 06/23/2005 | WO2005024039B1 Improved method for generating influenza viruses and vaccines |
| 06/23/2005 | WO2005023860A3 Modified il-4 mutein receptor antagonists |
| 06/23/2005 | WO2005023849A3 Antigenic peptides of rabies virus and uses thereof |
| 06/23/2005 | WO2005023833A3 Treatment of neurodegenerative diseases |
| 06/23/2005 | WO2005009358A3 Conformationally constrained parathyroid hormone (pth) analogs |
| 06/23/2005 | WO2005005630A3 Therapeutic use of lpi, a staphylococcal lectin pathway inhibitor in inflammatory diseases |
| 06/23/2005 | WO2005005471A3 Use of dg153 secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 06/23/2005 | WO2005005470A3 Pectin methylesterase inhibitors for the preparation of fruit juices and derivatives |
| 06/23/2005 | WO2005004592A9 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 06/23/2005 | WO2004113383A3 Pegylated soluble gp130-dimers useful as a medicament |
| 06/23/2005 | WO2004074462A3 Delta-endotoxin genes and methods for their use |
| 06/23/2005 | WO2004058986A3 Btl-ii nucleic acids, proteins, and antibodies |
| 06/23/2005 | WO2004052917A3 Hla-a1, a2 -a3,-a24,-b7,and -b44 tumor associated antigen peptides and compositions |
| 06/23/2005 | WO2004033655A3 Human organic solute transporters |
| 06/23/2005 | WO2004027079A3 Nuclear factor of activated t cells receptor |
| 06/23/2005 | WO2004018997A3 Methods and compositions for modulating amyloid beta |
| 06/23/2005 | WO2004003151A3 Protein production methods and modified cells for use therein |
| 06/23/2005 | WO2004000999A3 Identification of a receptor controlling migration and metastasis of skin cancer cells |
| 06/23/2005 | WO2003083078A3 Novel human cell surface protein with immunoglobulin folds, bgs-19 |
| 06/23/2005 | US20050138691 Nucleotide sequences plant transport protein for use as tool in identifying modulators of plant growth; herbicide resistance |
| 06/23/2005 | US20050138690 Expression vector comprising exogenous regulatory and gene sequences for use in generation of plants with tissue specific expression of heterologous gene product; improving exogenous gene expression |
| 06/23/2005 | US20050138687 Using viral cell-to-cell transfer as screening and diagnostic tool in identifying triple gene block 3 mutants; generating disease resistant plants |
| 06/23/2005 | US20050138686 Alternative splicing factors polynucleotides polypeptides and uses thereof |
| 06/23/2005 | US20050138685 Bacillus Cry9 family members |
| 06/23/2005 | US20050138684 For detecting a black-rot disease of a crucifer plant |
| 06/23/2005 | US20050138679 Method of evaluating useful cattle |
| 06/23/2005 | US20050138677 Transgenic animal model for the treatment of skin tumors |
| 06/23/2005 | US20050138676 Identification of genes involved in Alzheimer's disease using Drosophila melanogaster |
| 06/23/2005 | US20050138675 Using metallothionein, atrial natriuretic factor/peptide and/or heat shock transport protein expression in rodent animal model, after exposure to agent, as diagnostic indicator of cardiotoxic compounds |
| 06/23/2005 | US20050137387 Ancestral and COT viral sequences, proteins and immunogenic compositions |
| 06/23/2005 | US20050137384 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 06/23/2005 | US20050137329 homodimers of peptide monomers: (AcG)GLYACHMGPIT(1-nal)VCQPLR(MeG)0-1(K)0-1 each containing an intramolecular disulfide bond; spacer N1H (CH2)4 C4H N2H N1 in which N1 is covalently attached via a carbamate or an amide linkage to activated polyethylene glycol moiety; red blood cell production disorders |
| 06/23/2005 | US20050137159 Methods compositions and articles of manufacture for modulating bone growth |
| 06/23/2005 | US20050137157 administering polynucleotides coupled to thymidine kinase genes, that convert prodrugs such as acyclovir, ganciclovir, fialuridine or 6-methoxypurine arabinoside, to cytotoxic compounds, used for tissue targeted therapy in the treatment of pancreatic cancers |
| 06/23/2005 | US20050137138 E2F activity-inhibiting compound |
| 06/23/2005 | US20050137137 Inhibitors of the Interaction between p53 and MDM2 |
| 06/23/2005 | US20050137135 Novel analogues of glucose-dependent insulinotropic polypeptide |
| 06/23/2005 | US20050137133 nonimmunogenic water soluble polypeptides coupled to hydrophilic polymers, used as thrombopoietin agonist for the treatment of thrombocytopenia; blood disorders |
| 06/23/2005 | US20050137131 UspA1 and UspA2 antigens of Moraxella catarrhalis |
| 06/23/2005 | US20050137129 polypeptides comprising amino acid sequences coded by polynucleotides, expression vector and recombinant cells for producing the polypeptides used as wound healing agents |
| 06/23/2005 | US20050137128 Modulators of ß-amyloid peptide aggregation |
| 06/23/2005 | US20050136539 Generating immortalized human renal proximal tubule epithelial cell (RPTEC) for use as model for identifying modulators of renal toxicity |
| 06/23/2005 | US20050136521 Separating a target protein (such as a recombinant protein produced in a cell culture) from a mixture by contacting mixture with a hydrophobic adsorbent comprising branched hydrocarbon functional groups in an aqueous salt solution and collecting the unbound flow-through fraction containing the target |
| 06/23/2005 | US20050136515 Nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of cell proliferative, inflammatory, nervous system and autoimmune diseases |
| 06/23/2005 | US20050136514 Related to sodium/glucose cotransporter subfamily; drug screening; biochips; host cells |
| 06/23/2005 | US20050136512 Modified g-protein for use in identifying modulators for enhancement of taste and smell; screening ligand binding activity |
| 06/23/2005 | US20050136511 GABA B receptors |
| 06/23/2005 | US20050136498 Using pregnancy-associated plasma protein-A (PAPP-A) as diagnostic indicator of cardiovascular and atherosclerotic disorders |
| 06/23/2005 | US20050136491 Method of site specific labeling of proteins and uses therefor |
| 06/23/2005 | US20050136489 Biomarkers for liver diseases and method for using the same |
| 06/23/2005 | US20050136488 Identifying population of cells expressing fusion protein construct via fluorescent signal; diagnosing cancer |
| 06/23/2005 | US20050136484 Method for screening agents for the treatment of diabetes |
| 06/23/2005 | US20050136482 In vitro methods for determining in vivo thrombotic events |
| 06/23/2005 | US20050136476 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins and uses thereof |
| 06/23/2005 | US20050136475 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/23/2005 | US20050136474 Truncation SELEX method |
| 06/23/2005 | US20050136473 Breast specific nucleotide sequences for use as tools in diagnosis, prevention and treatment mammary gland cell proliferative disorders; rational drug design; antitumor agents |
| 06/23/2005 | US20050136467 Neuregulin fusion comprising epidermal growth factor domain for use in treatment and prevention of nervous system and neurodegenerative disorders |
| 06/23/2005 | US20050136461 Human megakaryocyte-associated tyrosine kinase (MATK)-related gene variant associated with lung cancers |
| 06/23/2005 | US20050136456 Nucleotide sequences coding epidermal growth factor polypeptide for use in diagnosis, prevention and treatment of cell and metabolic disorders; pharmacogenomic; drug screening and design |
| 06/23/2005 | US20050136451 Hypoxia responsive human CNGH 0002 genes and polypeptides |
| 06/23/2005 | US20050136445 Recombinant DNA vector, recombinant bio-luminescent bacterium and method for detecting bio-inhibitory substances using same |
| 06/23/2005 | US20050136435 Amino acid sequences for use in diagnosis, prevention and detection of cancer |
| 06/23/2005 | US20050136434 Isolated heat-inducible cell surface protein and hyperthermia-based tumor immunotargeting therapy |
| 06/23/2005 | US20050136422 Neisseria spp. polypeptide, nucleic acid sequence and uses thereof |
| 06/23/2005 | US20050136418 Signal transducer and activator of transcription-6 (STAT) gene sequences comprising mutation for use as tool in detect of asthmatic, autoimmune, inflammatory and fibrotic disorders |
| 06/23/2005 | US20050136404 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics |
| 06/23/2005 | US20050136402 Cancer antigen peptide and/or major histocompatibility complex binding sites for use as tools in detection and tretment of cell proliferative disorders; immunotherapy; genetic vaccine |
| 06/23/2005 | US20050136401 Method and device for detecting feline immunodeficiency virus |
| 06/23/2005 | US20050136400 NS3-NS4A protease resistance mutants |
| 06/23/2005 | US20050136103 Compositions capable of facilitating penetration across a biological barrier |
| 06/23/2005 | US20050136076 Immunogenic detoxified mutants of cholera toxin |
| 06/23/2005 | US20050136071 Hsp70 from arthrobacter |
| 06/23/2005 | US20050136070 Isolation and characterization of the csa operon (ETEC-CS4 Pili) and methods of using same |
| 06/23/2005 | US20050136069 Immunogenic portion of Mycobacterium tuberculosis proteins and monophosphoryl lipid A as adjuvant; vaccines |
| 06/23/2005 | US20050136067 Multimeric hybrid gene having a gene sequence coding for an antigenic region of a protein from a first pathogen linked to a gene sequence coding for an antigenic region of a protein from a second pathogen, especially coding for a parainfluenza virus and a respiratory syncytial virus; vaccines |
| 06/23/2005 | US20050136061 Anti-retroviral agents, compositions, methods and uses |
| 06/23/2005 | US20050136058 Insulin-like growth factor binding protein (IGFBP-5) |
| 06/23/2005 | US20050136054 Humanised antibodies |
| 06/23/2005 | US20050136047 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 06/23/2005 | US20050136046 Methods of using therapeutic fibrinogen compositions |
| 06/23/2005 | US20050136045 Can be administered by continuous infusion or by single intravenous bolus injection; use in the treatment of arterial thrombosis and for treating myocardial infarction; reduced antigenicity and immunogenicity as compared to wild-type staphylokinase |
| 06/23/2005 | US20050136043 Transforming Growth Factor (TGF); peptide that inhibits TGF beta signaling and/or Smad2 phosphorylation; mimetics; use with known enzyme inhibitors such as pyridinylimidazole drugs SB203580, SB202190, SB202474, PD169316, and SC68376; use e.g. treating tumors |
| 06/23/2005 | US20050136041 Transgenic cell comprising nucleotide sequences coding erythropoietin and/or glucagon-like peptides for use in treatment and prevention of blood and metabolic disorders; somatic and germ cell gene therapy; tissue engineering |
| 06/23/2005 | US20050136005 Methods for modulation of cholesterol transport |
| 06/23/2005 | US20050136004 Biosynthesis of biodrug by inoculating an animal with a polypeptide; producing antibodies of cytokine suppressive antiinflammatory drugs; antibody is modified with polyoxyethylene glycol; inflammatory bowel disease, ulcerative colitis, Crohn's disease, arthritis, and psoriasis |
| 06/23/2005 | US20050132969 Inducing sterility in fish by disrupting the development of the GnRH system |
| 06/23/2005 | DE10354403A1 Gegen das Prothrombin-Fragment F 1+2 gerichtete Antikörper, ihre Herstellung und Verwendung Against the prothrombin fragment 1 + F 2 directed antibody, their preparation and use |
| 06/23/2005 | CA2832293A1 Single nucleotide polymorphisms associated with cardiovascular disorders and statin response, methods of detection and uses thereof |